Form EFFECT FibroBiologics, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 16, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FibroBiologics (FBLG) files for 12.53M share offering by selling stockholders
- Above Food Provides Update on Nasdaq Listing Review Process and Engages Dickson Wright to Represent Company in Appeal
- AIR Clears Major Regulatory Milestone as FAA Accepts Power-Lift Standards Under MOSAIC Framework
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share